IBDEI10A ; ; 19-NOV-2015
 ;;3.0;IB ENCOUNTER FORM IMP/EXP;;JUN 29, 2015
 Q:'DIFQR(358.3)  F I=1:2 S X=$T(Q+I) Q:X=""  S Y=$E($T(Q+I+1),4,999),X=$E(X,4,999) S:$A(Y)=126 I=I+1,Y=$E(Y,2,999)_$E($T(Q+I+1),5,99) S:$A(Y)=61 Y=$E(Y,2,999) X NO E  S @X=Y
Q Q
 ;;^UTILITY(U,$J,358.3,16732,1,4,0)
 ;;=4^N84.9
 ;;^UTILITY(U,$J,358.3,16732,2)
 ;;=^5015869
 ;;^UTILITY(U,$J,358.3,16733,0)
 ;;=N95.2^^88^853^60
 ;;^UTILITY(U,$J,358.3,16733,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,16733,1,3,0)
 ;;=3^Postmenopausal Atrophic Vaginitis
 ;;^UTILITY(U,$J,358.3,16733,1,4,0)
 ;;=4^N95.2
 ;;^UTILITY(U,$J,358.3,16733,2)
 ;;=^270577
 ;;^UTILITY(U,$J,358.3,16734,0)
 ;;=N95.0^^88^853^61
 ;;^UTILITY(U,$J,358.3,16734,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,16734,1,3,0)
 ;;=3^Postmenopausal Bleeding
 ;;^UTILITY(U,$J,358.3,16734,1,4,0)
 ;;=4^N95.0
 ;;^UTILITY(U,$J,358.3,16734,2)
 ;;=^97040
 ;;^UTILITY(U,$J,358.3,16735,0)
 ;;=R97.2^^88^853^25
 ;;^UTILITY(U,$J,358.3,16735,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,16735,1,3,0)
 ;;=3^Elevated PSA
 ;;^UTILITY(U,$J,358.3,16735,1,4,0)
 ;;=4^R97.2
 ;;^UTILITY(U,$J,358.3,16735,2)
 ;;=^5019748
 ;;^UTILITY(U,$J,358.3,16736,0)
 ;;=N42.9^^88^853^63
 ;;^UTILITY(U,$J,358.3,16736,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,16736,1,3,0)
 ;;=3^Prostate Disorder,Unspec
 ;;^UTILITY(U,$J,358.3,16736,1,4,0)
 ;;=4^N42.9
 ;;^UTILITY(U,$J,358.3,16736,2)
 ;;=^5015698
 ;;^UTILITY(U,$J,358.3,16737,0)
 ;;=N40.1^^88^853^65
 ;;^UTILITY(U,$J,358.3,16737,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,16737,1,3,0)
 ;;=3^Prostate,Enlarged w/ Lower Urinary Tract Symptoms
 ;;^UTILITY(U,$J,358.3,16737,1,4,0)
 ;;=4^N40.1
 ;;^UTILITY(U,$J,358.3,16737,2)
 ;;=^5015690
 ;;^UTILITY(U,$J,358.3,16738,0)
 ;;=N40.0^^88^853^66
 ;;^UTILITY(U,$J,358.3,16738,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,16738,1,3,0)
 ;;=3^Prostate,Enlarged w/o Lower Urinary Tract Symptoms
 ;;^UTILITY(U,$J,358.3,16738,1,4,0)
 ;;=4^N40.0
 ;;^UTILITY(U,$J,358.3,16738,2)
 ;;=^5015689
 ;;^UTILITY(U,$J,358.3,16739,0)
 ;;=N41.9^^88^853^64
 ;;^UTILITY(U,$J,358.3,16739,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,16739,1,3,0)
 ;;=3^Prostate Inflammatory Disease,Unspec
 ;;^UTILITY(U,$J,358.3,16739,1,4,0)
 ;;=4^N41.9
 ;;^UTILITY(U,$J,358.3,16739,2)
 ;;=^5015694
 ;;^UTILITY(U,$J,358.3,16740,0)
 ;;=C61.^^88^853^62
 ;;^UTILITY(U,$J,358.3,16740,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,16740,1,3,0)
 ;;=3^Prostate Cancer
 ;;^UTILITY(U,$J,358.3,16740,1,4,0)
 ;;=4^C61.
 ;;^UTILITY(U,$J,358.3,16740,2)
 ;;=^267239
 ;;^UTILITY(U,$J,358.3,16741,0)
 ;;=N40.3^^88^853^67
 ;;^UTILITY(U,$J,358.3,16741,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,16741,1,3,0)
 ;;=3^Prostate,Nodular w/ Lower Urinary Tract Symptoms
 ;;^UTILITY(U,$J,358.3,16741,1,4,0)
 ;;=4^N40.3
 ;;^UTILITY(U,$J,358.3,16741,2)
 ;;=^5015692
 ;;^UTILITY(U,$J,358.3,16742,0)
 ;;=N40.2^^88^853^68
 ;;^UTILITY(U,$J,358.3,16742,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,16742,1,3,0)
 ;;=3^Prostate,Nodular w/o Lower Urinary Tract Symptoms
 ;;^UTILITY(U,$J,358.3,16742,1,4,0)
 ;;=4^N40.2
 ;;^UTILITY(U,$J,358.3,16742,2)
 ;;=^5015691
 ;;^UTILITY(U,$J,358.3,16743,0)
 ;;=Z87.430^^88^853^56
 ;;^UTILITY(U,$J,358.3,16743,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,16743,1,3,0)
 ;;=3^Personal Hx of Prostatic Dysplasia
 ;;^UTILITY(U,$J,358.3,16743,1,4,0)
 ;;=4^Z87.430
 ;;^UTILITY(U,$J,358.3,16743,2)
 ;;=^5063493
 ;;^UTILITY(U,$J,358.3,16744,0)
 ;;=N41.2^^88^853^1
 ;;^UTILITY(U,$J,358.3,16744,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,16744,1,3,0)
 ;;=3^Abscess of Prostate
 ;;^UTILITY(U,$J,358.3,16744,1,4,0)
 ;;=4^N41.2
 ;;^UTILITY(U,$J,358.3,16744,2)
 ;;=^270416
 ;;^UTILITY(U,$J,358.3,16745,0)
 ;;=N41.0^^88^853^69
 ;;^UTILITY(U,$J,358.3,16745,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,16745,1,3,0)
 ;;=3^Prostatitis,Acute
 ;;^UTILITY(U,$J,358.3,16745,1,4,0)
 ;;=4^N41.0
